Patents by Inventor Eoin McKinney

Eoin McKinney has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR PREDICTING AUTOIMMUNE DISEASE RISK
    Publication number: 20120003228
    Abstract: The invention relates to means and methods for determining whether a subject is at high or low risk of autoimmune disease progression by determining the CD8 or CD4 cell subtype of the subject. Autoimmune diseases of particular interest include vasculitis, systemic lupus erythematosus (SLE), rheumatoid arthritis, multiple sclerosis, and inflammatory bowel disease. The invention also relates to means and methods for determining the CD8 or CD4 cell subtype of a subject, e.g. for predicting responses to infection, vaccination and/or transplantation.
    Type: Application
    Filed: January 20, 2010
    Publication date: January 5, 2012
    Applicant: Cambridge Enterprise Limited
    Inventors: Ken Smith, Paul Lyons, Eoin McKinney
  • Genetic indicators of tobacco consumption
    Patent number: 7745112
    Abstract: There are disclosed genetic screens for predicting the likely extent of tobacco consumption in human subjects based on screening for the presence or absence of genetic variants shown to be associated with tobacco consumption in smokers.
    Type: Grant
    Filed: November 24, 2000
    Date of Patent: June 29, 2010
    Assignee: g-Nostics Limited
    Inventors: Robert Walton, Eoin McKinney, Sara Marshall, Michael Murphy, Kenneth Welsh